Concepedia

Publication | Open Access

A multicentre comparison between Child Pugh and Albumin‐Bilirubin scores in patients treated with sorafenib for Hepatocellular Carcinoma

92

Citations

17

References

2016

Year

Abstract

Our findings support the use CP class A as an inclusion criterion, and ALBI as a stratification factor in trials of systemic therapy.

References

YearCitations

2015

27.2K

1973

7.9K

2012

5.2K

2000

2.9K

2014

2.6K

2007

1.7K

2005

633

1966

292

2001

278

2015

243

Page 1